KRAS and overgrowth syndrome: Using our tissue analysis workflow including 17 genes associated with overgrowth syndrome, also no pathogenic variant could be identified, whereas LB analysis identified KRAS (NM_004985.5) c.35G>A p.(Gly12Asp) in plasma with a measured VAF of 1.01% (Table 2).